A Multicenter Study of LY188011 in Anthracyclines and Taxanes Pre-Treated Metastatic/Recurrent Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2009 Planned end date changed from 1 Aug 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 08 Dec 2008 Status changed from completed to active, no longer recruiting, as reported in ClinicalTrials.gov record.